Laboratory tests are vital throughout many clinical pathways. There are at least three major areas where in vitro diagnostics can provide essential contributions to diagnose and manage care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, and epidemiologic surveillance. In addition, lab results are at the forefront of identifying dangerous comorbidities that could have a negative impact on the prognosis of affected patients. Join Professor Mario Plebani and Professor Shu Kui Wang to learn how laboratory medicine could efficiently contribute to counteract the COVID-19 outbreak.
WHAT YOU WILL LEARN
- SARS-CoV-2 outbreak: key responses from the clinical laboratory
- COVID-19 and comorbidities: major predictors of severity
- How to identify immune response to the virus
Prof. Mario Plebani
Full Professor of Clinical Chemistry and Clinical Molecular Biology,
University of Padova, School of Medicine
Chief, Department of Laboratory Medicine,
University Hospital of Padova
Prof. Shu Kui Wang
Deputy Secretary, Vice Dean
Director Of Central Laboratory
Nanjing First Hospital, Nanjing Medical University,
This activity is approved for 1.0 ACCENT continuing education credits. Activity ID# 1994. This activity was planned in accordance with ACCENT Standards and Policies.